The global biopharmaceutical company Pharming Group has joined Pharma.Aero as a member of the Life Sciences Manufacturers Advisory Platform. Dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases, Pharming is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines, including small molecules and biologics. Headquartered in Leiden, the Netherlands, the company has employees around the globe serving patients in over 30 markets in North America, Europe, the Middle East, Africa, and Asia-Pacific.

By signing up for the LMAP, Pharming Group joins a select group of industry leaders: MSD, Pfizer, Zoetis, Novartis, Bayer, Astra Zeneca’s Alexion, GSK, Johnson & Johnson, Euromed Pharma, EarlyHealth Group, Galapagos, and Germinare.

Pharma.Aero established the Life Science Manufacturers Advisory Platform (LMAP) to further engage the manufacturing segment to provide first-line advice on the activities and projects of Pharma.Aero and support the logistics and supply chain industry. The LMAP integrates into all Pharma.Aero cross-industry initiatives and provide content value to the organization.